283 related articles for article (PubMed ID: 29483358)
1. Bruton's Tyrosine Kinase Is Not Essential for B Cell Survival beyond Early Developmental Stages.
Nyhoff LE; Clark ES; Barron BL; Bonami RH; Khan WN; Kendall PL
J Immunol; 2018 Apr; 200(7):2352-2361. PubMed ID: 29483358
[TBL] [Abstract][Full Text] [Related]
2. Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
Case JB; Bonami RH; Nyhoff LE; Steinberg HE; Sullivan AM; Kendall PL
J Immunol; 2015 Jul; 195(1):61-70. PubMed ID: 26034172
[TBL] [Abstract][Full Text] [Related]
3. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
[TBL] [Abstract][Full Text] [Related]
4. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
Middendorp S; Hendriks RW
J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
[TBL] [Abstract][Full Text] [Related]
5. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
6. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
[TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
8. Absence of mature peripheral B cell populations in mice with concomitant defects in B cell receptor and BAFF-R signaling.
Hoek KL; Carlesso G; Clark ES; Khan WN
J Immunol; 2009 Nov; 183(9):5630-43. PubMed ID: 19843948
[TBL] [Abstract][Full Text] [Related]
9. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
[TBL] [Abstract][Full Text] [Related]
10. MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses.
Alugupalli KR; Akira S; Lien E; Leong JM
J Immunol; 2007 Mar; 178(6):3740-9. PubMed ID: 17339472
[TBL] [Abstract][Full Text] [Related]
11. Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.
Kendall PL; Moore DJ; Hulbert C; Hoek KL; Khan WN; Thomas JW
J Immunol; 2009 Nov; 183(10):6403-12. PubMed ID: 19841184
[TBL] [Abstract][Full Text] [Related]
12. BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase.
Tumang JR; Negm RS; Solt LA; Schneider TJ; Colarusso TP; Hastings WD; Woodland RT; Rothstein TL
J Immunol; 2002 Mar; 168(6):2712-9. PubMed ID: 11884437
[TBL] [Abstract][Full Text] [Related]
13. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
[TBL] [Abstract][Full Text] [Related]
14. Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.
Middendorp S; Dingjan GM; Hendriks RW
J Immunol; 2002 Mar; 168(6):2695-703. PubMed ID: 11884435
[TBL] [Abstract][Full Text] [Related]
15. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
[TBL] [Abstract][Full Text] [Related]
16. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
[TBL] [Abstract][Full Text] [Related]
17. Btk Supports Autoreactive B Cell Development and Protects against Apoptosis but Is Expendable for Antigen Presentation.
Nyhoff LE; Griffith AS; Clark ES; Thomas JW; Khan WN; Kendall PL
J Immunol; 2021 Dec; 207(12):2922-2932. PubMed ID: 34799428
[TBL] [Abstract][Full Text] [Related]
18. Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement.
Kersseboom R; Ta VB; Zijlstra AJ; Middendorp S; Jumaa H; van Loo PF; Hendriks RW
J Immunol; 2006 Apr; 176(8):4543-52. PubMed ID: 16585544
[TBL] [Abstract][Full Text] [Related]
19. Modeling the clinical phenotype of BTK inhibition in the mature murine immune system.
Benson MJ; Rodriguez V; von Schack D; Keegan S; Cook TA; Edmonds J; Benoit S; Seth N; Du S; Messing D; Nickerson-Nutter CL; Dunussi-Joannopoulos K; Rankin AL; Ruzek M; Schnute ME; Douhan J
J Immunol; 2014 Jul; 193(1):185-97. PubMed ID: 24899507
[TBL] [Abstract][Full Text] [Related]
20. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.
Maas A; Dingjan GM; Grosveld F; Hendriks RW
J Immunol; 1999 Jun; 162(11):6526-33. PubMed ID: 10352268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
